Multidrug-resistant tuberculosis management in resource-limited settings.

Area of Science:

• Public Health
• Infectious Diseases
• Global Health

Background:

• Successful multidrug-resistant tuberculosis (MDRTB) management evidence primarily comes from high-income countries.
• Resource-limited settings face unique challenges in managing MDRTB.
• The Green Light Committee initiative facilitates access to essential drugs for MDRTB treatment.

Purpose of the Study:

• To evaluate the effectiveness of MDRTB management in five resource-limited countries.
• To assess treatment outcomes for new and previously treated MDRTB patients in these settings.
• To compare MDRTB management outcomes in resource-limited versus high-income countries.

Main Methods:

• Retrospective analysis of 1047 MDRTB patients across Estonia, Latvia, Peru, the Philippines, and the Russian Federation.
• Inclusion of patients receiving treatment through or in collaboration with national TB programs.
• Utilizing quality-assured second-line drugs provided at reduced prices via the Green Light Committee.

Main Results:

• Overall treatment success rate was 70% for all patients.
• New MDRTB patients had a higher success rate (77%) compared to previously treated patients (69%).
• A significant proportion of previously treated patients (over 50%) and all patients (65%) had resistance to both first- and second-line drugs.

Conclusions:

• MDRTB treatment in resource-limited settings, when supported by national TB programs, can achieve outcomes similar to those in wealthier nations.
• Effective MDRTB management is feasible even with high levels of drug resistance.
• Collaboration with initiatives like the Green Light Committee is crucial for drug access and successful treatment outcomes.